Patent intelligence · US
US 11752223
Method for producing Ac-225 solution and method for producing medicine using Ac-225 solution
Method for producing Ac-225 solution and method for producing medicine using Ac-225 solution
Patent details — US 11752223
- Jurisdiction
- US
- Status
- granted
- Grant date
- Sep 12, 2023
- Expiration
- Sep 7, 2043
- Claims
- 5
- CPC classes
- A61K, A61K51/0497, A61K51/088
Quick answer
US 11752223 (Method for producing Ac-225 solution and method for producing medicine using Ac-225 solution) is held by NATIONAL INSTITUTES FOR QUANTUM SCIENCE AND TECHNOLOGY. Status: granted. Granted Sep 12, 2023. Expires Sep 7, 2043 (17 years remaining) — relevant for patent-cliff and LOE planning.
Key facts
- Grant date
- Expiration
- Claims
- 5
- CPC classes
- A61K, A61K51/0497, A61K51/088
More from NATIONAL INSTITUTES FOR QUANTUM SCIENCE AND TECHNOLOGY
Related pharmaceutical patents in our USPTO index.
-
US 12391720
Salts and polymorphs of cethromycin for the treatment of disease
granted -
US 12377151
Immobilized endoglycosidase fusion protein and use thereof
granted -
US 12370266
Polymer composite nanomaterial encapsulation system
granted -
US 12318457
Oligosaccharide linker, linker-payload comprising the same and glycan chain-remodeled antibody-drug conjugate, preparation methods and uses thereof
granted -
US 12312377
Biconjugatable labels and methods of use
granted -
US 12195454
Compounds for imaging tau proteins that accumulate in the brain
granted -
US 12102694
Radiolabeled compound producing method and producing apparatus, radiolabeled compound and radioisotope producing apparatus
granted -
US 11999748
Exatecan derivatives, linker-payloads, and conjugates and thereof
granted
Related coverage
BBSW AI Solution: Key Insights from the 2026 Event
The BBSW AI Solution event in Foster, USA, promises to unveil critical advancements in AI technology for the pharma industry. Stay tuned for live updates and key takeaways.
BBSW AI Solution 2026: Key Insights and Highlights
The BBSW AI Solution event in 2026 is set to unveil groundbreaking advancements in AI technology. Join us for live coverage and key insights from industry leaders.
Frequently asked questions
What is US patent 11752223?
US 11752223 (Method for producing Ac-225 solution and method for producing medicine using Ac-225 solution) is held by NATIONAL INSTITUTES FOR QUANTUM SCIENCE AND TECHNOLOGY. Status: granted. Granted Sep 12, 2023. Expires Sep 7, 2043 (17 years remaining) — relevant for patent-cliff and LOE planning.
Who owns US 11752223?
NATIONAL INSTITUTES FOR QUANTUM SCIENCE AND TECHNOLOGY is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 36 pharmaceutical patents for this assignee.
When does US 11752223 expire?
Our index shows an expiration date of Sep 7, 2043 (17 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.